NCT06168487View on ClinicalTrials.gov

Telmisartan in Prostate Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 22, 2024

Primary Completion Date

April 1, 2026

Study Completion Date

April 1, 2027

Conditions
Prostate Cancer
Interventions
DRUG

Telmisartan

Patients will be given telmisartan alone or with standard of care chemotherapy.

OTHER

Standard of Care Regimen

Standard of Care Regimen

Trial Locations (1)

03756

RECRUITING

Dartmouth Health, Lebanon

All Listed Sponsors
lead

Tyler J Curiel

OTHER